A simple protein-based surrogate neutralization assay for SARS-CoV-2

Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a humoral immune response to the virus within a few weeks of infection, but the duration of this response and how it correlates with clinical outcomes has not been completely characterized. Of parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kento T., Li, Zhijie, Samson, Reuben, Samavarchi-Tehrani, Payman, Valcourt, Emelissa J., Wood, Heidi, Budylowski, Patrick, Dupuis, Alan P., Girardin, Roxie C., Rathod, Bhavisha, Wang, Jenny H., Barrios-Rodiles, Miriam, Colwill, Karen, McGeer, Allison J., Mubareka, Samira, Gommerman, Jennifer L., Durocher, Yves, Ostrowski, Mario, McDonough, Kathleen A., Drebot, Michael A., Drews, Steven J., Rini, James M., Gingras, Anne-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566699/
https://www.ncbi.nlm.nih.gov/pubmed/32870820
http://dx.doi.org/10.1172/jci.insight.142362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566699/
https://www.ncbi.nlm.nih.gov/pubmed/32870820
http://dx.doi.org/10.1172/jci.insight.142362

Ejemplares similares